| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| KIR2DL2 |
P43627
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 2
|
Receptor
|
|
0.612 |
0.654 |
| KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| IGF2-AS |
Q6U949
|
IGF2 antisense RNA
|
|
|
0.612 |
0.615 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| LINC01193 |
|
long intergenic non-protein coding RNA 1193
|
|
|
0.565 |
0.692 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| WG |
|
Wegener granulomatosis
|
|
|
0.595 |
0.808 |
| CXADRP1 |
|
CXADR pseudogene 1
|
|
|
0.463 |
0.846 |
| LINC01250 |
|
long intergenic non-protein coding RNA 1250
|
|
|
0.743 |
0.231 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| LINC00993 |
|
long intergenic non-protein coding RNA 993
|
|
|
0.729 |
0.269 |
| ANKRD30A |
Q9BXX3
|
ankyrin repeat domain 30A
|
|
2.7E-45 |
0.678 |
0.346 |
| SPG7 |
Q9UQ90
|
SPG7 matrix AAA peptidase subunit, paraplegin
|
Enzyme
|
2.0E-36 |
0.436 |
0.885 |
| LRRK2 |
Q5S007
|
leucine rich repeat kinase 2
|
Kinase
|
2.6E-30 |
0.510 |
0.808 |
| ERAP2 |
Q6P179
|
endoplasmic reticulum aminopeptidase 2
|
Enzyme
|
1.0E-28 |
0.615 |
0.577 |